Moderna’s mRNA COVID-19 vaccine candidate was the first U.S. shot to enter late-stage testing, but that does not necessarily mean it has the brightest future of all. The high possibility of multiple emergency authorizations for coronavirus vaccines towards the end of the year speaks to a lot of competition – …
Read More »
Text size Data from BioNTech and Pfizer were particularly promising. Jeenah Moon / Getty Images After a hiatus from a late summer break, the news of a Covid-19 vaccine is heating up again as a handful of leading programs are rapidly moving to a decisive phase. Reports from several companies …
Read More »
Text size Data from BioNTech and Pfizer were particularly promising. Jeenah Moon / Getty Images After a hiatus from a late summer break, the news of a Covid-19 vaccine is heating up again as a handful of leading programs are rapidly moving to a decisive phase. Reports from several companies …
Read More »
(Photo by Joe Raedle / Getty Images) Getty Images Text size Here’s what you need to know about the impact of Covid-19 to navigate the markets today. • President Donald Trump said Friday that McKesson would work with the U.S. government to spread a coronavirus vaccine if one is approved. …
Read More »
(Reuters) – US drug developer Novavax Inc said on Friday that the UK would buy 60 million doses of its coronavirus vaccine candidate, NVX-CoV2373. FILE PHOTO: A woman holds a small bottle labeled “Vaccine COVID-19” and a medical syringe in this illustration April 10, 2020. REUTERS / Dado Ruvic / …
Read More »